The human skin is an evolutionary masterpiece of defense, but a logistical nightmare for medicine. At the heart of this barrier is the stratum corneum, the outermost layer of the epidermis. As described by HM Ji et al. in Penetration Enhancement Effect of Turpentine Oil on Transdermal Film of Ketorolac, this layer acts as an exceptionally effective physical barrier that severely restricts the entry of therapeutic molecules into the bloodstream.
To understand why it works so well, imagine a "brick-and-mortar" structure where dead skin cells (corneocytes) are the bricks and highly ordered lipid domains act as the mortar (Poonam Rishishwar et al. in Formulation and ex vivo skin permeation of lidocaine HCl topical gels using dillenia (Dillenia indica L.) fruit gum). This crystalline lipid arrangement creates immense resistance, leading to slow penetration rates and delayed onset for conventional topical formulations (Poonam Rishishwar et al. in USE OF CASHEW BARK EXUDATE GUM IN THE PREPARATION OF 4 % LIDOCAINE HCL TOPICAL GELS).
This barrier limits everything from the transdermal bioavailability of botanical oils (Biao Che in Active Ingredients of Schisandra chinensis Fruit Oil and their Effect on Propionibacterium acnes-Induced Inflammation in HaCaT Cells) and anti-aging metabolites (Li Tan et al. in The anti-aging potential of VA’S new derivatives through metabolomic profiling) to large nano-vesicles like exosomes (Wenjing Li et al. in The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases). Even anatomical variations alter this resistance; for instance, the structural thickness of glabrous skin on human fingertips creates a significant barrier that delays how topical agents reach deep dermal mechanoreceptors (Scinob Kuroki et al. in Sanshool on The Fingertip Interferes with Vibration Detection in a Rapidly-Adapting (RA) Tactile Channel).
Pathological Sequestration and the "Trap" Effect
The problem intensifies when the skin is diseased. In conditions like psoriasis or hypertrophic scars, the skin undergoes hyperkeratosis and dramatic epidermal thickening (Lipeng Tang et al. in Punicalagin Alleviates Psoriasis by Inhibiting NF-κB-Mediated IL-1β Transcription and Caspase-1-Regulated IL-1β Secretion; Hongyao Du et al. in Microneedle-assisted percutaneous delivery of methotrexate-loaded nanoparticles enabling sustained anti-inflammatory effects in psoriasis therapy).
Crucially, this pathologically altered tissue does not just block molecules—it actively alters diffusion kinetics by acting as a sequestration compartment. As demonstrated by Manfred Bodenlenz et al., a thickened stratum corneum functions as a reservoir or trap that sequesters topical agents, slowing their initial diffusion into the underlying dermis and resulting in a delayed onset of action and lower initial bioavailability (Kinetics of Clobetasol-17-Propionate in Psoricial Lesional and Non-Lesional Skin Assessed by Dermal Open Flow Microperfusion with Time and Space Resolution).
Similarly, the dense, abnormal matrix of hypertrophic scars severely limits the penetration of conventional topical treatments (Yan Wo et al. in Enhanced in Vivo Delivery of 5-Fluorouracil by Ethosomal Gels in Rabbit Ear Hypertrophic Scar Model). This limited permeability prevents active compounds from reaching deep-seated or visceral components of lesions, restricting the efficacy of localized treatments for deep tumors or vascular malformations (Bingyu Xiu et al. in Additive Therapeutic Effects of Topical Sirolimus Following Oral Propranolol Therapy for Kaposiform Hemangioendothelioma).
Physical Microporation via Microneedles
To achieve therapeutic drug concentrations through the skin, researchers must deploy specialized permeation-promoting technologies that can be categorized into physical, chemical, or pharmacological mechanisms (Yaran Lei et al. in Delivery Strategies for Colchicine as a Critical Dose Drug: Reducing Toxicity and Enhancing Efficacy).
The most direct physical strategy is microneedle (MN) technology. Instead of attempting to diffuse through the dense lipid matrix, microneedles physically bypass the stratum corneum by creating temporary micropores (Dongdong Li et al. in Progress and perspective of microneedle system for anti-cancer drug delivery). This mechanism allows therapeutic agents to penetrate directly into the dermal layer, overcoming the limitations of conventional topical delivery methods.
By mechanically piercing the barrier, microneedles significantly enhance the delivery of poorly soluble drugs compared to standard gels (Hong Xiang et al. in Particle Size Effect of Curcumin Nanocrystals on Transdermal and Transfollicular Penetration by Hyaluronic Acid-Dissolving Microneedle Delivery). This approach enables the painless transdermal delivery of systemic treatments (Yang Ping et al. in Construction of microneedle of Atractylodes macrocephala Rhizoma aqueous extract and effect on mammary gland hyperplasia based on intestinal flora) and allows large anti-cancer agents or sustained-release nanoparticles to penetrate deep into hyperkeratotic lesions, bypassing the mechanical resistance of toughened tissue (Dongdong Li et al.; Hongyao Du et al.).
Chemical Fluidization and Nanoparticulate Navigation
When physical disruption is not ideal, chemical and pharmacological strategies can alter the barrier properties of the skin itself.
Chemical penetration enhancement utilizes specific agents to act as a "chemical crowbar." For instance, terpene-based agents like turpentine oil work by reversibly disrupting the highly ordered lipid structure of the stratum corneum (HM Ji et al. in Penetration Enhancement Effect of Turpentine Oil on Transdermal Film of Ketorolac). By fluidizing these lipid domains, chemical enhancers reduce the skin's barrier resistance and increase the flux of therapeutic agents into systemic circulation. Similarly, incorporating chemical enhancers like menthol into bio-based fruit gums can accelerate skin permeation rates to provide rapid localized pain relief (Poonam Rishishwar et al. in Formulation and ex vivo skin permeation of lidocaine HCl topical gels using dillenia (Dillenia indica L.) fruit gum).
Pharmacological nanocarriers offer a third pathway by re-engineering the drug vehicle to navigate dense biological matrices. Ethosomes, for example, possess unique elastic properties that facilitate deeper and more widespread distribution within the dense, abnormal tissue characteristic of hypertrophic scars (Yan Wo et al. in Enhanced in Vivo Delivery of 5-Fluorouracil by Ethosomal Gels in Rabbit Ear Hypertrophic Scar Model). For hydrophobic or poorly soluble compounds, specialized nanoemulsion gels can optimize transdermal delivery, allowing active ingredients to bypass the stratum corneum and reach target tissues in sufficient therapeutic concentrations (Xin Cheng et al. in Nanotechnology-driven nanoemulsion gel for enhanced transdermal delivery of Sophora alopecuroides L. empyreumatic oil: formulation optimization, and anti-biofilm efficacy).
Key Foundational Work
Enhanced in Vivo Delivery of 5-Fluorouracil by Ethosomal Gels in Rabbit Ear Hypertrophic Scar Model (2014) — contributed 3 concept elements to this direction.
Penetration Enhancement Effect of Turpentine Oil on Transdermal Film of Ketorolac (2015) — contributed 2 concept elements to this direction.